Sophie L. Corthals

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

Annemiek Broyl, Sophie L. Corthals, Joost L.M. Jongen et al. · The Lancet Oncology · 2010 · 220 citations

Hematological Malignancy, Neuro-oncology, Peripheral Neuropathy +8

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

Jacqueline Cloos, Bianca F. Goemans, Corine J. Hess et al. · Leukemia · 2006 · 176 citations

Prognostic Influence, Systems Biology, Engineering +10

Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma

David C. Johnson, Sophie L. Corthals, Brian A. Walker et al. · Journal of Clinical Oncology · 2011 · 98 citations · Full text

Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

David C. Johnson, Sophie L. Corthals, Christine Ramos et al. · Blood · 2008 · 65 citations · Full text

Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma

Sophie L. Corthals, Mojca Jongen‐Lavrencic, Yvonne de Knegt et al. · Leukemia Research · 2009 · 58 citations

Hematological Malignancy, Tumor Biology, Micro-rna-16 Expression +8